Literature DB >> 15254186

Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Santanu Bose1, Mausumi Basu, Amiya K Banerjee.   

Abstract

Human parainfluenza virus type 3 (HPIV-3) is an airborne pathogen that infects human lung epithelial cells from the apical (luminal) plasma membrane domain. In the present study, we have identified cell surface-expressed nucleolin as a cellular cofactor required for the efficient cellular entry of HPIV-3 into human lung epithelial A549 cells. Nucleolin was enriched on the apical cell surface domain of A549 cells, and HPIV-3 interacted with nucleolin during entry. The importance of nucleolin during HPIV-3 replication was borne out by the observation that HPIV-3 replication was significantly inhibited following (i). pretreatment of cells with antinucleolin antibodies and (ii). preincubation of HPIV-3 with purified nucleolin prior to its addition to the cells. Moreover, HPIV-3 cellular internalization and attachment assays performed in the presence of antinucleolin antibodies and purified nucleolin revealed the requirement of nucleolin during HPIV-3 internalization but not during attachment. Thus, these results suggest that nucleolin expressed on the surfaces of human lung epithelial A549 cells plays an important role during HPIV-3 cellular entry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254186      PMCID: PMC446124          DOI: 10.1128/JVI.78.15.8146-8158.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus.

Authors:  J S Salas-Benito; R M del Angel
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Bipolar functional expression of transcobalamin II receptor in human intestinal epithelial Caco-2 cells.

Authors:  S Bose; S Seetharam; N M Dahms; B Seetharam
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

Review 3.  The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection.

Authors:  C C Rider
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.

Authors:  A Moscona; R W Peluso
Journal:  Microb Pathog       Date:  1996-03       Impact factor: 3.738

5.  The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.

Authors:  E Bacharach; J Gonsky; K Alin; M Orlova; S P Goff
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans.

Authors:  S Nisole; B Krust; C Callebaut; G Guichard; S Muller; J P Briand; A G Hovanessian
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

7.  The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate.

Authors:  S A Feldman; S Audet; J A Beeler
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection.

Authors:  L K Hallak; P L Collins; W Knudson; M E Peeples
Journal:  Virology       Date:  2000-06-05       Impact factor: 3.616

9.  Characterization of the oligomerization domain of the phosphoprotein of human parainfluenza virus type 3.

Authors:  Suresh K Choudhary; Achut G Malur; Yunwen Huo; Bishnu P De; Amiya K Banerjee
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

10.  beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex.

Authors:  Y S Tao; R A Edwards; B Tubb; S Wang; J Bryan; P D McCrea
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

View more
  34 in total

1.  Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles.

Authors:  Corey A Balinsky; Hana Schmeisser; Sundar Ganesan; Kavita Singh; Theodore C Pierson; Kathryn C Zoon
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 2.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

3.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 4.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

5.  Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor.

Authors:  Xiaodong Xiao; Yang Feng; Zhongyu Zhu; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2011-06-23       Impact factor: 3.575

Review 6.  RNA-binding protein nucleolin in disease.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  RNA Biol       Date:  2012-05-23       Impact factor: 4.652

7.  Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.

Authors:  Srikanth Kota; Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Yan Xiang; Xiangzhi Meng; Santanu Bose
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

8.  Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection.

Authors:  Katherina Goris; Sabine Uhlenbruck; Christel Schwegmann-Wessels; Wiebke Köhl; Frank Niedorf; Michael Stern; Marion Hewicker-Trautwein; Robert Bals; Geraldine Taylor; Armin Braun; Gerd Bicker; Manfred Kietzmann; Georg Herrler
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

9.  Stat1 nuclear translocation by nucleolin upon monocyte differentiation.

Authors:  Uwe Jerke; Sergey Tkachuk; Julia Kiyan; Victoria Stepanova; Angelika Kusch; Michael Hinz; Rainer Dietz; Hermann Haller; Bianca Fuhrman; Inna Dumler
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  Anticancer oncolytic activity of respiratory syncytial virus.

Authors:  I Echchgadda; S Kota; I DeLa Cruz; A Sabbah; T Chang; R Harnack; V Mgbemena; B Chatterjee; S Bose
Journal:  Cancer Gene Ther       Date:  2009-05-15       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.